Inside of a new study, we noted the identification and also the characterization of a whole new atypical opioid receptor with distinctive negative regulatory properties to opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can also be a broad-spectrum sc